Braveheart Bio, Inc. Common Stock BRVE
$25.02
-14.32%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-09-08 | View → |
| 8-K | 8-K | 2026-09-08 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-10 | View → |
| 4 | 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 8-K | 8-K | 2026-08-07 | View → |
| S-1 | S-1 | 2026-07-15 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $25.02
- Market Cap
- $2.25 billion
- 52-Week Range
- $24.30 – $32.00
- Average Volume
- 455K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.